Al-Hendy Laboratory - The University of Chicago
The Al-Hendy laboratory uses methods of basic, translational, clinical, and community-based research to address important medical diseases. Areas of research focus include the developmental origin of gynecologic conditions, such as …
Ayman Al-Hendy - Wikipedia
Ayman Al-Hendy, (born January 24, 1964) is a professor and director of translational research from Department of Obstetrics and Gynecology, University of Chicago.
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Mar 2, 2023 · Ayman Al-Hendy, MD, PhD, is a highly skilled gynecologist who specializes in comprehensive women’s health. Dr. Al-Hendy delivers expert care for complex gynecologic conditions, including uterine fibroids, infertility and endometriosis.
Ayman Al-hendy - Google Scholar
A Al-Hendy, AS Lukes, AN Poindexter III, R Venturella, C Villarroel, ... New England Journal of Medicine 384 (7), 630-642, 2021. 189: 2021: Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. MA Borahay, A Al-Hendy, GS Kilic, D Boehning.
Ayman Al-Hendy | New Faculty 2020 - University of Chicago
Ayman Al-Hendy ’s research has focused on understanding the origin of gynecologic conditions that result in infertility, such as uterine fibroids, endometriosis, and premature ovarian failure, as well as the development of novel treatments.
Research | Department of Pediatrics
Al-Hendy is a Gynecologist and Endoscopic Surgeon at UC Medical Center, Chicago, Illinois with a busy practice that focuses on serving women with symptomatic uterine fibroids and premature ovarian insufficiency.
Uterine Fibroids Research - UChicago Medicine
Al-Hendy and his research consortium remain focused on expanding treatment options for patients with fibroids. They are currently studying green tea extract’s (epigallocatechin gallate, or EGCG) potential ability to shrink fibroids.
Al-Hendy Lab Members - University of Chicago
The University of Chicago Obstetrics & Gynecology 5841 South Maryland Ave Chicago, IL 60637 773.702.6118 © 2025 The University of Chicago
Ayman Al-Hendy | Profiles RNS - University of Chicago
Aug 9, 2021 · Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
Ayman AL-hendy - Khalifa University
Primary prevention of uterine fibroid via early detection of molecular secretome signal and vaccine development. Novel Stem cell based Therapeutics for female and male fertility restoration and …